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All archaea have a chaperonin of Group II (thermosome) in their cytoplasm and some
have also a chaperonin of Group I (GroEL; Cpn60; Hsp60). Conversely, all bacteria have
GroEL, some in various copies, but only a few have, in addition, a chaperonin (tentatively
designated Group III chaperonin) very similar to that occurring in all archaea, i.e., the
thermosome subunit, and in the cytosol of eukaryotic cells, named CCT. Thus, nature
offers a range of prokaryotic organisms that are potentially useful as experimental models
to study the human CCT and its abnormalities. This is important because many diseases,
the chaperonopathies, have been identified in which abnormal chaperones, including
mutant CCT, are determinant etiologic-pathogenic factors and, therefore, research is
needed to elucidate their pathologic features at the molecular level. Such research should
lead to the clarification of the molecular mechanisms underlying the pathologic lesions
observed in the tissues and organs of patients with chaperonopathies. Information on
these key issues is necessary to make progress in diagnosis and treatment. Some of
the archaeal organisms as well as some of the bacterial models suitable for studying
molecular aspects pertinent to human mutant chaperones are discussed here, focusing
on CCT. Results obtained with the archaeon Pyrococcus furiosus model to investigate
the impact of a pathogenic CCT5 mutation on molecular properties and chaperoning
functions are reviewed. The pathogenic mutation examined weakens the ability of
the chaperonin subunit to form stable hexadecamers and as a consequence, the
chaperoning functions of the complex are impaired. The future prospect is to find means
for stabilizing the hexadecamer, which should lead to a recovering of chaperone function
and the improving of lesions and clinical condition.
Keywords: chaperonopathies, Group II chaperonins, experimental models, archaea, CCT-like chaperonin in
bacteria, CCT5 mutations, Pyrococcus furiosus, hexadecamer instability
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INTRODUCTION
The realization that abnormal chaperones can be determinant
etiologic-pathogenic factors has revealed the need to develop
means for studying the molecular mechanisms involved. A
number of questions still require answers if progress is to be
made in the elucidation of the mechanism of disease and thereby,
in early diagnosis and treatment. For instance: What is the
impact of a pathogenic mutation on the intrinsic properties (e.g.,
stability in the face of stress, and flexibility) of the chaperone
molecule? and What is the effect of these mutations on the
chaperoning and non-chaperoning functions (e.g., protection of
other proteins from denaturation by stressors, dissolution of
fibrillar protein deposits, assistance in the folding of a nascent
polypeptide, interaction with cells of the innate immune system)
of the chaperone? In order to find answers to these key questions,
experimental models are necessary. In this review, we provide
information on archaeal organisms and on some exceptional
bacteria that carry Groups I and II (or Group II-like) chaperonin
genes, which have potential as experimental models to study
human chaperonopathies.
SCOPE AND OBJECTIVE
This review encompasses the emerging field that comprises
the use of archaeal organisms and some recently identified
bacteria with archaeal-like chaperonins for studying issues
directly relevant to human Medicine. The focus is on Group
II chaperonins and associated genetic chaperonopathies. The
main objective is to present this novel area of research to the
scientific community so interest in these serious diseases might
be ignited and projections into other similar disorders might be
perceived. It is hoped that innovative research on these and many
other conditions with comparable etiopathogenic characteristics,
involving abnormal chaperones, will be initiated applying the
prokaryotic models discussed.
CHAPERONE GENES AND ASSOCIATED
CHAPERONOPATHIES
Diseases caused by mutations in molecular chaperone genes, the
genetic chaperonopathies, are being diagnosed with increasing
frequency and numerous examples representing the main
chaperone families have been reported. For instance, concerning
the chaperonins, among the latest reports of mutations associated
with disease one pertains to HSPE1 (Bie et al., 2016) and another
to the cct2 gene (Minegishi et al., 2016). It may be assumed that
many more cases of this kind of diseases will be found when
the medical community becomes aware of the existence and
high prevalence of chaperonopathies, genetic and acquired. To
gain perspective on the potential scope of chaperonopathies one
may recall the number of chaperone genes that have so far been
identified in the human genome: at least 17 for Hsp70 (Brocchieri
et al., 2008); 14 for CCT, and one for Hsp60 (HSPD1, Cpn 60)
(Mukherjee et al., 2010; Bross and Fernandez-Guerra, 2016); 10
for the sHsp with the alpha-crystallin domain, one for Hsp10
(HSPE1, Cpn10), five for Hsp90, and nearly 50 for Hsp40/DnaJ
(Kappé et al., 2003, 2010; Kampinga et al., 2009; Macario et al.,
2013; Bross and Fernandez-Guerra, 2016). Furthermore, one
has to include the many molecules such as co-chaperones and
chaperone cofactors and closest interactors-receptors that, in
addition to the chaperones themselves, integrate the chaperoning
system. Thus, it is certain that there are many more diseases
or syndromes associated with mutations or post-translational
modifications of chaperones and closely associated molecules
than those that have been identified to date.
In this article, we will focus on the chaperonins of Group II,
namely the CCT chaperonins, since there are reports on diseases
caused by mutations of human cct genes. Fourteen cct genes,
including canonical and non-canonical family members, have
been identified in the human genome (Table 1; Mukherjee et al.,
2010), and mutations in several of them have been found to cause
heritable disease (Table 2).
The clinical features and mode of inheritance of genetic
chaperonopathies, including those caused by mutations of
chaperonin genes, are in general well characterized (see for
instance Bouhouche et al., 2006a; Bross and Fernandez-Guerra,
2016). However, the molecular mechanisms causing the cellular,
tissue, and organ lesions observed in patients are still poorly
understood. Likewise, the impact of these pathogenic mutations
on the intrinsic properties and chaperoning functions of the
chaperonin molecules has not yet been characterized in vivo or
in vitro to a satisfactory extent. More research and especially,
more experimental models are necessary to boost progress in
this area of Medicine pertaining to chaperonopathies. In this
regard, prokaryotes offer interesting possibilities. All bacteria
possess chaperonins of Group I and some species also have
chaperonins more closely related to Group II (Techtmann and
Robb, 2010). All archaea have Group II chaperonins and some
also possess chaperonins of Group I (Table 3; Deppenmeier et al.,
2002; Galagan et al., 2002; Conway de Macario et al., 2003;
Laksanalamai et al., 2004; Maeder et al., 2005; Large and Lund,
2009). In archaea, the chaperonins of Group II are present in
various modes: some have only one gene/subunit while others
have two, three, four, or five genes/subunits (Figure 1). As
indicated in the figure, in all cases studied so far the archaeal
Group II subunits associate to form hexadecamers made of two
stacked octameric rings just like the human CCT subunits do.
BACTERIA WITH GROUP II-LIKE (GROUP
III) CHAPERONINS
Many species of Bacteria have multiple Hsp60 (Cpn60)
chaperonin genes. This is especially notable in the Agrobacterium
group, in the Firmicutes, and in the Alphaproteobacteria (Lund,
2009). In these bacteria, the multiple GroEL/ES homologs
presumably carry out complementary protein-folding and -
quality control activities and in some cases for which genetic
systems are available, the essential and nonessential copies of the
Cpn60 gene could be identified (Lund, 2001). In addition, the
two Cpn60 homologs of Mycobacterium tuberculosis can act as
cytokines with modulation of inflammatory responses (Qamra
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TABLE 1 | The human hsp60-cct gene extended familya.
Name Alternative names Stb Chr Ex Is aa
CCT1 TCP1, CCTa, CCTα, TCP-1α – 6q25.3 12, 7 2 556, 401
CCT2 CCTβ, TCP-1β + 12q15 14 1 535
CCT3 CCTγ, TCP-1γ – 1q23.1 13, 13, 12 3 545, 544, 507
CCT4 CCTδ, TCPD, TCP-1δ – 2p15 13 1 539
CCT5 CCTε, TCP1E, TCP-1ε + 5p15.2 11 1 541
CCT6A CCTζ , CCTζ1, TCP-1ζ , CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20 + 7p11.2 14, 13 2 531, 486
CCT6B CCTζ -2, TCP-1ζ -2, Cctz2, TSA303, Tcp20 – 17q12 14 1 530
CCT7 CCTη, TCP-1η, Ccth, NIP7-1 + 2p13.2 12, 7 2 543, 339
CCT8 CCTθ, TCP-1θ, Cctq – 21q21.3 15 1 548
CCT8L1 LOC155100 + 7q36.1 1 1 557
CCT8L2 GROL, CESK1 – 22q11.1 1 1 557
MKKS BBS6 – 20p12.2 4, 4 2 570, 570
BBS10 C12orf58, FLJ23560 – 12q21.2 2 1 723
BBS12 C4orf24, FLJ35630, FLJ41559 + 4q27 1 1 710
HSPD1 GROEL, HSP60, Hsp60, SPG13, CPN60, Cpn60, HuCHA60 – 2q33.1 11, 11 2 573, 573
PIKFYVE CFD, FAB1, PIP5K, PIP5K3 + 2q34 5 1 224
aSource: Mukherjee et al., 2010.
bSt, DNA strand with positive or negative signs indicating sequenced or complementary strand respectively; Chr, chromosome location; Ex, number of exons; Is, number of isoforms or
mRNA variants, in which multiple numbers indicate the number of exons in each isoform; aa, total number of amino acids encoded in the gene; PIKFYVE, Fab1_TCP sequence domain
of the PIKFYVE kinase, most similar to the apical domain of CCT3, in which features refer to the domain portion of the gene/protein.
TABLE 2 | Diseases associated with mutations in genes encoding chaperonins and in genes phylogenetically related to the CCT familya.
GENE/Name/HGNC/Gene ID/UniProtKB/Swiss-Prot/Accession number Chaperonopathies. Mutations
CCT2/1615/10576/P78371/NM_006431 OMIM: 605139. Leber congenital amaurosis (LCA): hereditary, early-onset congenital
retinopathy with macular degeneration. Mutations T400P and R516H. See Minegishi
et al., 2016.
CCT4/1617/10575/P50991/NM_006430 OMIM: *605142. Distal hereditary sensory neuropathy (mutilated foot) in rat. Mutation
C450Y.
CCT5/1618/22948/P48643/NM_012073.3 OMIM: *610150; #256840. Distal hereditary sensory-motor neuropathy. Mutation
H147R. See description in this article.
MKKS/7108/8195/Q9NPJ1/NM_018848.2 & NM_170784.1 OMIM: 04896 gene; 209900 phenotype; 236700 phenotype; BBS6 605231;
McKusick-Kaufman syndrome; MKKS hydrometrocolpos syndrome;
hydrometrocolpos, postaxial polydactyly, and congenital heart malformation; HMCS
Kaufman-Mckusick syndrome. Y37C (604896.0003), T57A (604896.0010), and
C499S (604896.0013): increased MKKS degradation and reduced solubility relative to
wildtype MKKS, and the mutant H84Y (604896.0001). R155L, A242S, and G345E
mutations: increased MKKS degradation only.
BBS10/26291/79738/Q8TAM1/NM_024685.3 OMIM: 610148 gene; 209900 phenotype; BBS10 615987; Bardet-Biedl syndrome 10;
ciliopathy with obesity, retinitis pigmentosa, polydactyly, hypogonadism, and renal
failure. 209900) a 1-bp insertion at residue 91 leading to premature termination 4
codons later (C91fsX95). V11G; R34P; S303FS; S311A.
BBS12/26648/166379/Q6ZW61/NM_152618.2 OMIM: 610683 Phenotypes OMIN: BBS12 615989 Bardet-Biedl syndrome 12. A289P;
R355T; 3-BP DEL, 335TAG; 2-BP DEL, 1114TT; 2-BP DEL, 1483GA; F372fsX373.
HSPD1/5261/3329/P10809/NM_199440.1 & NP_955472.1 OMIM: 605280 Spastic Paraplegia 13, autosomal dominant; SPG13, V98I; Q461E.
See Bross and Fernandez-Guerra, 2016.
OMIM: 612233 Leukodystrophy, Hypomyelinating, 4; HLD4; Mitochondrial HSP60
Chaperonopathy; MitCHAP60 Disease. Mutation D29G. See Bross and
Fernandez-Guerra, 2016.
HSPE1/5269/3336/61604.2/NM_002157.2 & NP_002148.1 OMIM: *600141 Neurological and developmental disorder characterized by infantile
spasms. Mutation L73F. See Bie et al., 2016.
aSource: Macario and Conway de Macario, 2005; Mukherjee et al., 2010; Macario et al., 2013; Minegishi et al., 2016. Clinical and pathological features are described in the references
cited and in the URLs shown.
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TABLE 3 | Examples of archaea with both, Group I and II chaperonin
genesa.
Organism Chaperonin genes of Group:
I II (subunits)
Methanococcus vannielii SB 1 1
Methanospirillum hungatei JF-1 1 2
Methanosarcina barkeri str. Fusaro 1 3
Methanosarcina mazei Go1 1 3
Methanosarcina acetivorans C2A 1 5
aSource: Deppenmeier et al., 2002; Galagan et al., 2002; Conway deMacario et al., 2003;
Maeder et al., 2005; Large and Lund, 2009.
FIGURE 1 | Chaperonins of Group I and II in archaea and humans. Top
left: archaeal CCT-complex equivalent, or thermosome; top center the CCT
chaperonin of Group II complex typically resident of the eukaryotic-cell cytosol;
and top right the chaperonin of Group I (Hsp60 or Cpn60) complex (with
Hsp10 on top) characteristic of bacteria and eukaryotic-cell mitochondria (the
former two are hexadecamers while the latter is a tetradecamer). Archaeal
species vary in their content of chaperonin genes-proteins from only one
through a maximum (at least from what we know at the present time) of five.
These subunits are variously designated with Arabic numbers, English letters,
or Greek letters. As far as we know, they all form a hexadecameric megadalton
sized complex, the thermosome, of the type shown on top to the left, which is
an example of a hexadecamer found in archaea encoding only one chaperonin
subunit, e.g., P. furiosus. The composition of hexadecamers in all archaea that
have two or more subunits is not yet fully elucidated. M. thermautotrophicus,
Methanothermobacter thermautotrophicus 1H, previously known as
Methanobacterium thermoautotrophicum 1H. M. mazei, Methanosarcina
mazei. Source: Macario et al., 1999, 2004; Conway de Macario et al., 2003;
Maeder et al., 2005; Large and Lund, 2009.
et al., 2005; Henderson et al., 2006, 2010). Given the predilection
ofM. tuberculosis for establishing cryptic infections, suppression
of the inflammation response may be an important aspect of its
molecular repertoire as a pathogen.
In a group of Bacteria with taxonomic common ground, an
archaeal-type chaperonin occurs in addition to the canonical
GroEL/ES operons. In these organisms, with one exception, the
Group II-like proteins, tentatively named Group III chaperonins
(Figure 2) are coded by genes that are embedded in the
DnaK(Hsp70)/DnaJ(Hsp40) operon, which encodes the Hsp70,
and DnaJ(Hsp40) homologs and the nucleotide exchange factor
GrpE.
Prefoldin (or Gim C), a holdase chaperone complex found in
the archaeal and eukaryal sequenced genomes, interacts directly
with the charged residues located in the apical domain in
Group II chaperonins (Vainberg et al., 1998; Sahlan et al., 2010;
Zako et al., 2016). This is a favored mode of client protein
delivery to the Group II chaperonin complex for refolding.
The absence of Prefoldin in bacterial genomes may imply that
another chaperone is partnering with the Group III chaperonin.
It is tempting to speculate that DnaK(Hsp70), which is encoded
in the same operon as most chaperonin III genes, and thus
likely to be coregulated, is functioning as a direct delivery
mechanism, a situation observed with eukaryotic homologs.
Alternatively, the Group III chaperonins may be able to function
efficiently without the assistance of a co-chaperone (Cuéllar
et al., 2008). The working relationship, if any, between the
chaperonins of Group I and Group III in bacteria that have
both, in protein homeostasis is not characterized yet. The
Group III chaperonins have been shown to provide robust
resistance to lethal heat shock exposures in Escherichia coli when
expressed as a single recombinant protein (Techtmann and Robb,
2010).
The crystal structure of the prototype Group III chaperonin
from Carboxydothermus hydrogenoformans has recently been
determined (An et al., 2016), and shows distinct structural
differences, which probably reveal functional differences,
between the Group II and Group III chaperonins (Figure 3).
Based on both the phylogenetic and functional differences in
the lid domain and the nucleotide-binding cavity (Figure 4),
we have proposed that this class be called the Group III Cpn60
clade (Rowland, 2016). The apical domain of the Group III
chaperonin was also shown to be divergent from Group II
chaperonins (Techtmann and Robb, 2010). The Group III
chaperonins may be thought to represent a remnant of the
common ancestor of the Group I and Group II chaperonins
(Techtmann and Robb, 2010). Alternatively, the genes may
have diverged from an early lateral gene transfer of a Group
II chaperonin from Archaea to Bacteria. In either event,
the allosteric mechanism of the Group III chaperonins is
similar to the Group II with the exceptions of divergence
in the apical domain and the lack of a nucleotide sensing
loop.
For the purposes of testing or mimicking the biochemical
effects of pathological mutations affecting, for instance, human
CCT genes, the Group III chaperonins may have unique
advantages. These include the ability of the prototype to
complement overtaxed stress responses of bacteria such as E.
coli, as it is expressed in soluble form and at high levels in
Bacteria (Techtmann and Robb, 2010). The crystal structure that
has been produced from this prototype also provides a scaffold
to determine the relative structural similarity to the regions of
the CCT homologs affected by pathogenic mutations (An et al.,
2016).
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FIGURE 2 | Bacteria with chaperonins close to Group II (tentatively designated Group III). Molecular phylogenetic analysis by Maximum Likelihood methods.
Groups I, II, and III, are in yellow, blue, and red, respectively. The evolutionary history was inferred by using the Maximum Likelihood method based on the JTT
matrix-based model (Jones et al., 1992). A heuristic search was applied with Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a
JTT model, and then selecting the topology with superior log likelihood value. The tree is drawn to scale, with branch lengths measured in the number of substitutions
per site. The analysis involved 190 full-length chaperonin amino-acid sequences. All positions containing gaps and missing data were eliminated. There were a total of
370 positions in the final dataset. Evolutionary analyses were conducted in MEGA7. The intial alignment was constructed using ClustalW default settings.
CCT5 PATHOGENIC MUTATION
We have been working with archaeal stress proteins and
chaperones for many years and are now using some archaea
as experimental models to investigate molecular features of
human chaperonopathies that are difficult to study directly,
in human samples. Here, we will briefly discuss an archaeal
experimental model that is providing interesting data pertaining
to the impact of a pathogenic mutation on the properties of the
chaperone molecule itself. The idea is that, by elucidating the
molecular abnormalities caused by the mutation, the road will
be opened to investigate the molecular mechanisms underlying
the tissue lesions observed in the patients with chaperonopathies.
Furthermore, biochemical and biophysical information insights
that accrue from these studies will help in designing therapeutic
strategies targeting the key steps of pathogenesis.
Along these lines, we are currently characterizing the
molecular abnormalities involved in the causation of the
pathological lesions observed in a human neuropathy associated
with a mutation of the CCT5 subunit. This neuropathy was
described in four members of a Moroccan family and was
characterized as an autosomal recessive, mutilating, sensory
neuropathy with spastic paraplegia (Bouhouche et al., 2006a,b).
Onset occurred between 1 and 5 years of age and the clinical and
pathological features were lower limb spasticity; hyperreflexia
with clonus; positive Babinski; subtle distal amyotrophy with
normal motor function; and distal sensory loss for all modalities
in the upper and lower limbs, particularly in the feet.
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FIGURE 3 | Crystal structure of prototype of Group III chaperonin.
Crystal structure of the prototype Group III chaperonin closed complex
(hexadecamer) from Carboxydothermus hydrogenoformans. The view is along
the equatorial plane and the individual, identical subunits are coded in different
colors for contrast to visualize the intersubunit contacts. The structure reveals
that the inter-ring contacts are formed by one-to-one associations between the
subunits in the equatorial plane and that the configuration of the apical domain
(“built-in lid”) differs from the lid region of Group II chaperonin complexes. The
method and preliminary structure have been described (An et al., 2016).
FIGURE 4 | ATP-binding sites of chaperonins of Group II and III.
Comparison of highly conserved putative ATP gamma-phosphate interacting
residue (denoted by asterisks) in group II (top) and group III (bottom)
chaperonins. Top: Logo created using WebLogo (Schneider and Stephens,
1990; Crooks et al., 2004) and ClustalW amino-acid sequences alignment of
26 Group II chaperonins including representatives from all eight eukaryotic
subunits and archaeal sequences. Bottom: Group III chaperonins alignment of
79 sequences pulled from NCBI database by BLAST against Ch cpn amino
acid sequence (Altschul et al., 1990).
Deformities of the hands and feet were recorded in two
patients, and most had deep perforating ulcers of the extremities.
Progression of spasticity was slow but the sensory neuropathy
FIGURE 5 | Human CCT5 and P. furiosus Pf-Cpn (Pf-CD1) superposed
onto the crystal structure of Thermococcus strain KS-1 subunit α
(1Q3Q). Left. The Pf-CD1 graphic representation (gold ribbon) was obtained in
Swiss-Model (http://swissmodel.expasy.org/) and superposed onto the crystal
structure of KS-1 subunit α (monomers are displayed in marine blue, violet,
and deep teal colors as surface, and in cyan color as ribbon). The whole
hexadecamer double-ring structure is depicted by a dotted line. Right.
Magnified image of the superposed structures of the Pf-CD1 (gold ribbon) and
Human CCT5 (orange ribbon) onto the KS-1 α subunit crystal structure
(1Q3Q; cyan ribbon). Side chains of isoleucine at 138 of Pf-CD1 (blue),
isoleucine at 138 of KS-1 subunit α (deep teal), and histidine at 147 of human
CCT5 (red) are represented as ball and stick. AMP-PNP (β,γ-Imidoadenosine
5′-triphosphate lithium salt hydrate; green stick) and magnesium ion (yellow
ball). Source: Min et al., 2014.
was rapidly progressive and severe. Magnetic resonance imaging
(MRI) of two patients showed severe atrophy of the spinal
cord.
AN ARCHAEAL EXPERIMENTAL MODEL
Archaea have not been used as models to specifically study
molecular aspects of human chaperonopathies until very recently
(Min et al., 2014). However, studies on the structure and
properties of the thermosome, the archaeal equivalent of
the human CCT, have been going on for nearly 30 years.
These studies of the thermosome have provided fundamental
information useful also to understand the structure and
mechanism of function of the eukaryotic counterpart. Here we
will first present a few illustrative examples of structural studies of
the thermosome and then, we will discuss the archaeal model we
utilized to investigate molecular aspects of the chaperonopathy
mentioned earlier, which is associated with mutations in the
CCT5 submit.
THE STRUCTURE OF THE ARCHAEAL
THERMOSOME
The archaeal thermosome has been the focus of study for
elucidating the structure of the multisubunit chaperoning
machine for many years and it continues to be a source of
valuable information applicable to the human CCT complex
(Waldmann et al., 1995; Ditzel et al., 1998; Bosch et al., 2000;
Pereira et al., 2010, 2012; Zhang et al., 2010; Lund, 2011; Skjærven
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FIGURE 6 | The pathogenic mutant causes a loss of ATPase activity
evidenced at various temperatures. Pf-CD1 (red squares), Pf-H (green
triangles), and Pf-R (purple stars). The results shown are mean values (±
standard deviations) and the experiments were carried out in triplicate. Source:
Min et al., 2014.
et al., 2015). For example, data supporting the notion that the
archaeal thermosome is the equivalent of the eukaryotic cytosolic
chaperonin CCT, also named TRiC (t-complex polypeptide 1
ring complex), were obtained over two decades ago by studying
the archaeon Thermoplasma acidophilum (Waldmann et al.,
1995). This pioneering work provided impetus to subsequent
investigations using the same organism to elucidate the functions
and structure of the chaperonin complex. Two thermosome
subunits are encoded in the T. acidophilus’ genome (Ruepp et al.,
2000, 2001; Large and Lund, 2009) termed a and b, or alpha
and beta. A crystal structure revealed that the T. acidophilus
thermosome is composed of two stacked octameric rings
composed of alternating a (alpha) and b (beta) subunits, with
the two rings being related by 2-fold symmetry, which generates
a-a (alpha-alpha) and b-b (beta-beta) pairs and brings about
an (ab)4(ab)4 arrangement with a 42-point symmetry (Ditzel
et al., 1998). The domains in the monomers follow a topology
similar to that of the GroEL monomer. The combined analysis
of the crystal structure and of multiple alignments of extended
primary sequences of various chaperonins helped to identify
in the linear sequence the now well-known three domains,
as follows, from the N to the C terminus: the N-terminal
segment of the equatorial domain, the N-terminal portion of
the apical domain, the intermediate domain, the C-terminal
segment of the apical domain, and the C-terminal segment
of the equatorial domain. This was a seminal contribution
useful to many researchers since it was reported. The way
rings make contact is different in the archaeal thermosome as
compared with the GroEL complex. Most importantly, it was
observed that the apical domains extend to build a sort of
lid that can close the entrance to the central cavity, playing
a similar role to that of GroES in the bacterial chaperonin
complex. The central cavity was found to have a polar surface
which suggested its implication in the process of substrate
folding.
In subsequent work, the crystal structure of the beta-apical
domain was determined at 2.8 Ångström resolution (Bosch
et al., 2000). A comparative analysis with previously determined
apical domain structures revealed in the T. acidophilum a
segmental displacement of the protruding part of helix H10
via the hinge GluB276-ValB278. Furthermore, the portion of
the molecule including the amino acids GluB245-ThrB253 was
found to be in an extended beta-like conformation in contrast
to the alpha-helix characteristic of the alpha-apical domain.
These conformational features prompted the suggestion that
apical domain projections could be the basis to provide a
variety of context-dependent conformations during an open,
substrate-accepting state during the ATP-dependent chaperoning
cycle.
Other structural studies with the archaeal thermosome were
carried out using Methanococcus maripaludis (Pereira et al.,
2010, 2012). The genome of M. maripaludis encodes only
one thermosome subunit (Hendrickson et al., 2004; Large and
Lund, 2009). The crystal structures of both, the open (substrate
acceptor) and closed (substrate folding) states were obtained
(Pereira et al., 2010). It was observed that the M. maripaludis
thermosome subunit remains rigid during the reorientation
accompanying the cycling of the complex. This is in sharp
contrast with what occurs with GroEL, in which the greatest
motion occurs at the intermediate and apical domains while
the equatorial domain conserves a similar conformation in the
open and closed states. Interestingly, the rotation occurring
from the open to the closed state decreases by 65% the
volume of the folding chamber whose surface becomes highly
hydrophilic.
In a subsequent study with M. maripaludis, the mechanism
responsible for communicating the local changes in the ATP-
binding site between subunits during the chaperoning cycle
were investigated (Pereira et al., 2012). The data obtained
provided fundamental information on the movements of
the thermosome components as they are engaged in the
various states of the chaperoning cycle. The crystal structures
of several ATP-bound states were determined and it was
observed that the amino acid Lys161, known to be much
conserved among Group II chaperonins, interacts with the
γ-phosphate of ATP and reorients in the presence of ADP.
It was found that the loss of the interaction ATP- γ-
phosphate in the ADP state is accompanied by considerably
rearrangement of the loop including amino acids 160–169.
It was proposed that Lys161 functions as an ATP sensor
and the loop is a nucleotide-sensing device whose function
would be to monitor the presence of γ-phosphate. Loop
mutants had considerably lower ATPase activity than the
wild type molecule, which suggested that the nucleotide-
sensing loop plays a critical role in synchronizing the folding
cycle.
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FIGURE 7 | Comparative analyses of protective capacity of mutant and wild type chaperonins. Protection from heat denaturation of malate dehydrogenase
(MDH) by mixed oligomers of Pf-CD1 (red square), Pf-H (green triangle), and Pf-R (purple star) at 37◦C (top left panel) and 42◦C (top right panel); and protection of
MDH at 37◦C (bottom left panel) and shrimp alkaline phosphatase (SAP) at 50◦C (bottom right panel) by pure hexadecamers. Negative control (no chaperonin added),
i.e., MDH, or SAP in bottom right panel, alone: blue diamond. The results shown are mean values (±SD) of triplicate experiments. The loss of enzymatic activity
caused by heat was impeded or considerably attenuated by the wild type and Pf-H molecules. In contrast, Pf-R did not have this protective effect, except when
purified hexadecamers were used. Source: Min et al., 2014.
TABLE 4 | Summary of results showing the functional performance of the pathogenic mutant Pf-R in comparison with non-pathogenic counterpartsa.
Gene E. coli exp. Mixed oligomers Hexadecamers
Heat res. ATPase Disperse fibrils Form hexa-decamers Protection
MDH MDH SAP
37◦C 42◦C 37◦C 50◦C
Pf-CD1 100 100 100 100 100 100 100 100 100
Pf-H 100 100 100 or less 100 or less 100 or less 100 100 100 100
Pf-R 100 100 Low Low Low Low Low 100 100
aSource: Min et al., 2014.
exp, expression; res, resistance; 100, optimal; MDH, malate dehydrogenase; SAP, shrimp alkaline phosphatase.
THE THERMOSOME OF PYROCOCCUS
FURIOSUS
We standardized an experimental model using the chaperonin
molecule from the archaeon Pyrococcus furiosus. This organism
has only one CCT ortholog (Robb et al., 2001) that forms an
hexadecameric chaperoning machine, the thermosome, with the
same overall structure as the human CCT complex, except that
all 16 subunits are identical (Figure 1). Therefore, simulating a
human CCT mutation on the P. furiosus chaperonin (Pf-Cpn)
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FIGURE 8 | The pathogenic mutant fails to disperse amyloid fibrils. Dispersion of amyloid fibrils by archaeal Pf-CD1 (top row of panels), partial dispersion by
Pf-H (middle row of panels), and no dispersion by Pf-R (bottom row of panels). Atomic Force Microscopy (AFM) of bovine insulin amyloid fibrils treated with Cpn and
Mg++, and ATP. Control panels, no added chaperonin. Scale bar: 250 nm. Source: Min et al., 2014.
subunit would amplify the impact of the human mutation 8-fold
per octameric ring, and facilitate detection of subtle functional
deficiencies caused by the mutation. Mutations causing major
functional deficits in human CCT are most likely lethal because
the chaperonin is essential for life; one can safely assume that
no phenotypes will be found associated with mutations causing
major, easily detectable functional failure of the chaperonin
molecule in vitro, or in vivo. Therefore, this strategy for
characterizing slight deficits in function may provide valuable
insights into pathogenic mechanisms. It has to be borne in
mind that if the mutation in one subunit of a hetero-oligomer
such as the human CCT affects primarily the interaction of the
non-identical subunits with each other, the use of an homo-
oligomeric model like that of P. furiosus may not fully report on
the impact of themutation. This considerationmust be taken into
account in interpreting experimental results with the two types of
oligomers.
We first established which amino acid position in the Pf-Cpn
matches that in the human CCT5 in which the mutation is found,
i.e., 147. In the wild type CCT5 the amino acid His is at this
position but in the pathogenic mutant His is replaced by Arg.
We found by a series of alignments and 3D modeling studies
that position 138 in Pf-Cpn is equivalent to the 147 position in
human CCT5 and it is occupied by Ile (Figure 5; information
on the primary and secondary structures is available in Min
et al., 2014). To examine the impact of the mutations we used
Pf-CD1, which is the recombinant molecule Pf-Cpn lacking the
last 22 amino acids that are involved in extreme heat resistance
and have no match in the human CCTs. We introduced the
pathogenic mutation Ile138Arg in Pf-CD1 to produce Pf-R, and
then proceeded to test the mutant in comparison with the wild
type to assess its properties and chaperoning capacity. We also
made and used for comparison another mutant, not known to be
pathogenic, Ile138His of Pf-CD1 (Pf-H).
We found that Pf-R had very low ATPase activity by
comparison with Pf-CD1 and Pf-H (Figure 6). Likewise, mixed
oligomers of Pf-R were deficient in protecting test enzymes from
heat denaturation (Figure 7), and were incapable of dispersing
amyloid fibrils in contrast to Pf-CD1 and Pf-H (Figure 8).
Remarkably, purified hexadecamers from the three molecules
had similar enzyme protection capability; namely, hexadecamers
formed by Pf-R had a chaperoning ability comparable to
that of Pf-CD1 and Pf-H (Figure 7). The summary of results
obtained with assays aimed at measuring the chaperoning
capacity of the mutant Pf-R are displayed in Table 4. In
conclusion, the Arg mutation affects the formation and stability
of functional hexadecamers. Indeed, in native PAGE, Pf-R
appears predominantly as oligomers smaller than hexadecamers
and as monomers in contrast to Pf-CD1 and Pf-H (Min et al.,
2014).
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It is possible that some part of the effects observed using
Pf-R by comparison with PF-CD1 were magnified somewhat
because in the archaeal mutant the wild type amino acid, Ile,
is hydrophobic and the mutant amino acid, Arg, is charged,
whereas in the human situation the two amino acids, wild type
and mutant, are charged, i.e., they are similar in this regard. For
this reason, we generated and characterized the Pf-H mutant as
control for any change that this charged residue might bring to
the stability of the complex, which turned out to beminimal (Min
et al., 2014).
We could not yet test isolated monomers because they tend
to oligomerize rapidly in solution. However, in silico analysis by
molecular dynamics simulations revealed that Pf-R monomers
are rigid at the physiological temperature whereas those of Pf-
CD1 are flexible; namely, the Ile138Arg mutation causes a loss of
flexibility in the chaperonin molecule, which is also the result we
obtained for the human mutant CCT5 (Min et al., 2014).
Experimentally, by applying quantitative calorimetry, current
experiments are showing that the Pf-R hexadecamers are less
resistant to heat and dissociate faster and at lower temperatures
as compared with Pf-CD1.
In conclusion, the use of the archaeal chaperonin provided
information that reflects the anomalies of the human mutant
CCT5, which has been studied in vitro (Sergeeva et al., 2014).
In a pioneering study, the human CCT4, and CCT5 subunits
have been shown to form homohexadecamer complexes after
expression of the subunits in E. coli (Sergeeva et al., 2013). The
chaperoning ability of wild type CCT4 and CCT5 was tested
in comparison with CCT4 C450Y and CCT5 H147R mutants.
The functional tests included the suppression of aggregation
of γD-crystallin and mutant huntingtin, and the refolding of
beta-actin. In all tests the mutant subunits formed complexes
with slightly deficient folding activities compare to the wild-type
counterpart, although these effects were minimal in the case of
CCT5 H147R. Both of the mutants produced were able to form
complexes, although CCT4 C450Y showed limited stability and
formed fewer megadalton-size complexes than CCT5 H147R.
This study reinforces our conclusion that the biochemical effects
of human mutations affecting the CCT5 complex, yet permitting
viability, must of necessity be slight, attesting to the central role
that we believe this complex plays in human protein homeostasis
and physiology.
PERSPECTIVES FOR THE FUTURE
In the particular case discussed above, future research ought to be
directed to the development of agents, e.g., chemical compounds,
with the ability to interact with the mutant chaperonin
molecule and restore its proper, functional configuration and
thus, boost its capacity to form stable hexadecamers. The
screening of compounds and preclinical testing could utilize
the same P. furiosus experimental model used to reveal
the abnormal features of the mutant CCT5 molecule. The
same approach would apply to chaperonopathies involving
other mutations in CCT5 that might be discovered, or
mutations in any other subunit. Likewise, the P. furiosus
model, as well as any other based on the archaeal and
bacterial organisms discussed here, could be standardized
and applied to elucidate the abnormalities of pathogenic
chaperone molecules due not only to mutations but also
to post-translational modifications. For example, Group III
chaperonins could be used for modeling defects in human
chaperonins involving the nucleotide sensing domain which,
as mentioned earlier, is divergent in the canonical and non-
canonical orthologs.
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